July 29, 2026 10:42 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Farmers storm Bhopal! Traffic crippled as protest over MSP intensifies | Supreme Court gives clean chit to Manmohan Singh in coal block scam case two years after death, accepts CBI closure report | Rahul Gandhi's 'student, idiot, andhbhakt' remark sparks uproar in Lok Sabha during anti-paper leak bill debate | Assam flood death toll climbs to 75; Over 3 lakh still affected as relief efforts intensify | 'You are simply useless': Kangana Ranaut hits back at CJP's Saurav Das in fresh Instagram attack | Assam floods: Death toll stays at 68 as over 5.24 lakh continue to battle deluge | 'Probe is meaningless if responsibility isn't fixed': Supreme Court slams Delhi Police over CJP protest crackdown | 'No protester will be left alone': CJP claims Centre shared FIR withdrawal copies after midnight talks | Bihar cop suspended after viral AK-47 firing video during NEET protest crackdown | After Dharmendra Pradhan's exit, 'E20 Janta Party' emerges, demands Nitin Gadkari's resignation over fuel policy
Photo courtesy: twitter.com/yogrishiramdev

SC issues contempt notice to Ramdev's Patanjali Ayurved, Acharya Balkrishna for misleading ads on medicines

| @indiablooms | Feb 28, 2024, at 04:16 am

New Delhi: The Supreme Court on Tuesday issued a show cause notice to Patanjali Ayurved and the company’s managing director Acharya Balkrishna for deviating from their promise to not make misleading claims in their product advertisements, media reports said.

The apex court put restrictions on the company co-founded by Yoga guru Baba Ramdev from circulating any advertisement with claims to cure illnesses such as high blood pressure, diabetes, fevers, epilepsy and lupus, which are mentioned in the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954, Moneycontrol reported.

The court slammed the company and criticised the government in strong words.

“The entire country is being taken for a ride" and the government is "sitting with its eyes closed," it said, according to the report.

Pulling up the government for lack of action, the court directed it to submit a sworn statement detailing measures implemented to curb companies' dissemination of inaccurate medication representations through the media.

Patanjali and its staff received a warning against disseminating any misleading claims regarding their product's capacity to treat illnesses.

This directive was issued in response to a writ petition filed by the Indian Medical Association (IMA) over misleading advertisements by certain companies.

In November, Patanjali had promised to refrain from publishing ads that made false claims about its products and disparaged modern medicines and vaccinations.

However, despite this commitment, Patanjali continued to run such advertisements, as reported to the court.

In November 2023, the court warned Patanjali and said, "All false and misleading advertisements by Patanjali Ayurved have to stop immediately. This court will take such infractions very seriously and will consider imposing costs of up to Rs 1 crore on every product for which a false claim is made that it can cure a particular disease."

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.